本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

维罗纳制药

105.17
+0.08000.08%
盘后105.05-0.1200-0.11%18:56 EDT
成交量:196.93万
成交额:2.07亿
市值:89.53亿
市盈率:-52.12
高:105.31
开:105.19
低:105.11
收:105.09
数据加载中...
2024/07/29

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/30

重要事件披露

Form 8-K - Current report
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/02

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities